← Evidence map

ArticleiScience2025

The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19.

Clara Hernández-Blanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39877904